Askari et al (2012)
The following study can be used to support the use of drug treatments for people with OCD. It focuses on granisetron, a drug that reduces serotonergic activity by binding to 5-HT(3) receptors on the postsynaptic membrane.This study may also be used on Paper 1 to answer a Biological Approach short answer questions about neurotransmission, including questions focused specifically on antagonists. Background information
To access the entire contents of this site, you need to log in or subscribe to it.
Alternatively, you can request a one month free trial.